Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealed

0:00-23:27

FDA extends its review of Capricor Therapeutics’ Duchenne muscular dystrophy cell therapy as an unhappy shareholder advocates for change; Merck and Moderna tout positive data for their mRNA-based cancer vaccine; Trump nominates White House aide Heidi Overton as FDA commissioner; and the oral obesity market heats up with rivals Eli Lilly and Novo Nordisk going head-to-head.

Publisher

BioSpace

Published

August 26, 2026

Duration

23 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

B

BioSpace

@biospace

#capricorsdmdtherapy #modernascancervax #fdasfuturerevealed #lifesciences

The Nile